Clinical trial
Efficacy and Safety of Intravenous IIaprazole for Peptic Ulcer Bleeding: A Randomized, Double-Blind, Omeprazole-Controlled, Multicenter, and Phase 3 Trail in China
NCT03362281 is registered in ClinicalTrials.gov with Livzon Pharmaceutical Group Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Intravenous IIaprazole for Peptic Ulcer Bleeding: A Randomized, Double-Blind, Omeprazole-Controlled, Multicenter, and Phase 3 Trail in China
- Lead sponsor
- Livzon Pharmaceutical Group Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- April 30, 2015
- Enrollment
- 540 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.